https://www.selleckchem.com/pr....oducts/crenolanib-cp
Post-operatively, cancer treatment was resumed in 58% of patients. An American Society of Anesthesiologists (ASA) score less-than III (odds ratio = 12.6 (95% confidence interval (CI) 2.9-54.6); p = 0.001) and a performance status less-than 3 (odds ratio = 9.7 (95% CI 1.4-67.2); p = 0.021) were associated with resuming post-operative cancer treatment. We found that ASA score and performance status are associated with resumption of cancer treatment post-operatively and should be taken into consideration when considering the t
Like
Comment
Share
